Incretin Effect on the Immunological Phenotype

NCT01782261 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Liraglutide
DRUG: Saxagliptin

Sponsor

Medical University of Graz